Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation and sepsis.

F R Machado1, E Silva

  • 1Napoleão de Barros 715 4a andar São Paulo, SP 04024-002, Brazil. genauhaus@uol.com.br

Endocrine, Metabolic & Immune Disorders Drug Targets
|June 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial experience in colorectal robotic surgery in a university hospital: the first 100 consecutive cases using Hugo™ RAS platform.

Techniques in coloproctology·2026
Same author

Associations between endometrial macrophages and persistence of endometritis in postpartum dairy cows.

Animal : an international journal of animal bioscience·2025
Same author

Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral PrEP in the United States.

BMC public health·2023
Same author

The impact of a drug allergy label in an internal medicine ward.

European annals of allergy and clinical immunology·2023
Same author

Transcatheter embolization of pulmonary artery pseudoaneurysm secondary to squamous-cell lung cancer.

Pulmonology·2022
Same author

Synoptic assessment of coastal total alkalinity through community science.

Environmental research letters : ERL [Web site]·2022
Same journal

Denosumab is Associated with Improved Liver Function and Reduced Fibrosis Scores in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease and Osteoporosis: A Retrospective Observational Study.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Semaglutide and Musculoskeletal Health: A Mendelian Randomization Study Based on GLP-1 Receptor Expression.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Expression of IL-35 in the Prophase of Liver Failure and its Immune Regulatory Interaction with Glucocorticoids.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Celastrol Attenuates Fgf23 Expression in Osteoblasts by Inhibiting STAT3 Activation.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Mendelian Randomization Analysis of the Inflammatory Factor CXCL5 and Type 2 Diabetes Mellitus.

Endocrine, metabolic & immune disorders drug targets·2026
Same journal

Clinical Exome Sequencing Study in a Cohort of Growth Hormone-Secreting Pituitary Adenomas.

Endocrine, metabolic & immune disorders drug targets·2026
See all related articles

Sepsis triggers an inflammatory response causing severe coagulation disorders. These issues lead to blood clots, reduced blood flow, and organ damage, highlighting the critical link between inflammation and sepsis-induced coagulopathy.

Area of Science:

  • Focuses on the intersection of immunology, hematology, and critical care medicine.
  • Explores the pathophysiology of sepsis and its impact on the coagulation system.

Background:

  • Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
  • Coagulation derangements are a hallmark of sepsis, significantly contributing to patient morbidity and mortality.

Purpose of the Study:

  • To review the primary mechanisms and consequences of coagulation disorders in sepsis.
  • To elucidate the role of the inflammatory storm in sepsis-induced coagulopathy.

Main Methods:

  • This is a review article, synthesizing existing literature on sepsis and coagulation.
  • Analysis of the inflammatory processes leading to exacerbated coagulation, impaired anticoagulation, and reduced fibrinolysis.

Related Experiment Videos

Main Results:

  • The inflammatory storm in sepsis drives coagulation abnormalities.
  • These abnormalities include hypercoagulability, impaired natural anticoagulant pathways, and deficient fibrin clot removal.
  • Microcirculation thrombosis, microclot deposition, and impaired blood flow leading to organ hypoperfusion and dysfunction are key outcomes.

Conclusions:

  • Coagulation derangements are central to the pathophysiology of sepsis-induced organ dysfunction.
  • Understanding these disorders is crucial for developing targeted therapeutic strategies in sepsis management.